Company / PP&E per Share
Veracyte, Inc. PP&E per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.25
FY2022
5-year range
$0.25 / $0.26
FY2018-FY2022
Trend
-4.1%
vs FY2021
Sector context
#116 of 133
Health Care
What the data says
Veracyte, Inc.'s pp&e per share of $0.25 is lower than 87% of companies in the Health Care sector (FY2022). Improved from $0.18 to $0.25 over the past 2 years.
Based on SEC 10-K filings.
0.25 in FY2022 with a 5-year CAGR of -2.8%.
Improved from $0.18 to $0.25 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 133This company $0.25 Sector average $11.65
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2022, pp&e per share decreased 4.1% year-over-year.
- Ranks #116 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.25 | -4.1% |
| FY2021 | $0.26 | +43.2% |
| FY2020 | $0.18 | -17.1% |
| FY2019 | $0.22 | -17.4% |
| FY2018 | $0.26 | -7.7% |
| FY2017 | $0.29 | -30.8% |
| FY2016 | $0.41 | -9.4% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026